These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: GABA(A) receptors containing the alpha4-subunit: prevalence, distribution, pharmacology, and subunit architecture in situ.
    Author: Benke D, Michel C, Mohler H.
    Journal: J Neurochem; 1997 Aug; 69(2):806-14. PubMed ID: 9231742.
    Abstract:
    Recombinant GABA(A) receptors, expressed from alpha-, beta-, and gamma2-subunits, are diazepam-insensitive when the alpha-subunit is either alpha4 or alpha6. In situ, diazepam-insensitive receptors containing the alpha6-subunit are almost exclusively expressed in the granule cell layer of the cerebellum. However, diazepam-insensitive receptors are also expressed in forebrain areas. Here, we report on the presence of diazepam-insensitive GABA(A) receptors in various brain areas containing the alpha4-subunit. GABA(A) receptors immunoprecipitated with a newly developed alpha4-subunit-specific antiserum displayed a drug binding profile that was indistinguishable from those of alpha4beta2gamma2-recombinant receptors and diazepam-insensitive [3H]Ro 15-4513 binding sites in rat brain membranes. In addition, alpha4-subunit containing receptors and forebrain diazepam-insensitive receptors are present at comparably low abundance in rat brain and exhibit virtually identical patterns of distribution. Analysis of the subunit architecture of alpha4-subunit containing receptors revealed that the alpha4-subunit contributes to several receptor subtypes. Depending on the brain region, the alpha4-subunit can be coassembled with a second type of alpha-subunit variant being alpha1, alpha2, or alpha3. The data demonstrate that native receptors containing the alpha4-subunit are structurally heterogeneous, expressed at very low abundance in the brain, and display the drug binding profile of diazepam-insensitive [3H]Ro 15-4513 binding sites. Pharmacologically, these receptors may contribute to the actions of nonclassical ligands such as Ro 15-4513 and bretazenil.
    [Abstract] [Full Text] [Related] [New Search]